Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13319
Title: | Effects of melatonin on severe crush spinal cord injury–induced reactive astrocyte and scar formation |
Authors: | Krityakiarana W. Sompup K. Jongkamonwiwat N. Mukda S. Pinilla F.G. Govitrapong P. Phansuwan-Pujito P. |
Keywords: | cytokine melatonin melatonin neuroprotective agent nonsteroid antiinflammatory agent animal cell animal experiment animal model animal tissue Article astrocyte controlled study disease control disease severity drug effect drug efficacy female immunohistochemistry mouse nerve crush nervous system inflammation nonhuman outcome assessment priority journal randomized controlled trial scar formation single drug dose spinal cord injury treatment response Western blotting animal animal behavior astrocyte convalescence drug effects locomotion metabolism nerve crush pathology psychology scar spinal cord injury Animals Anti-Inflammatory Agents, Non-Steroidal Astrocytes Behavior, Animal Cicatrix Female Locomotion Melatonin Mice Nerve Crush Neuroprotective Agents Recovery of Function Spinal Cord Injuries |
Issue Date: | 2016 |
Abstract: | The present work aimed at analyzing the effects of melatonin on scar formation after spinal cord injury (SCI). Upregulation of reactive astrocyte under SCI pathological conditions has been presented in several studies. It has been proved that the crucial factor in triggering this upregulation is proinflammatory cytokines. Moreover, scar formation is an important barrier to axonal regeneration through the lesion area. Melatonin plays an important role in reducing inflammation, but its effects on scar formation in the injured spinal cord remain unknown. Hence, we used the model of severe crush injury in mice to investigate the effects of melatonin on scar formation. Mice were randomly separated into four groups; SCI, SCI+Melatonin 1 (single dose), SCI+Melatonin 14 (14 daily doses), and control. Melatonin was administered by intraperitoneal injection (10 mg/kg) after injury. Immunohistochemical analysis, Western blot, and behavioral evaluation were used to explore the effects of melatonin after SCI for 14 days. The melatonin-treated mice presented higher expression of neuronal markers (P < 0.001). Remarkably, the inflammatory response appeared to be greatly reduced in the SCI+Melatonin 14 group (P < 0.001), which also displayed less scar formation (P < 0.05). These findings suggest that melatonin inhibits scar formation by acting on inflammatory cytokines after SCI. Overall, our results suggest that melatonin is a promising treatment strategy after SCI that deserves further investigation. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/13319 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988905763&doi=10.1002%2fjnr.23930&partnerID=40&md5=c3d1b31cc12f30ee81acf462bc02bdea |
ISSN: | 3604012 |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.